166 related articles for article (PubMed ID: 37739247)
1. Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures.
Li H; Lin WP; Zhang ZN; Sun ZJ
Acta Biomater; 2023 Dec; 172():1-15. PubMed ID: 37739247
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
[TBL] [Abstract][Full Text] [Related]
4. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.
Zhang K; Xie X; Zou LH; Guo SQ
Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
[TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
[TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy.
Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ
Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991
[TBL] [Abstract][Full Text] [Related]
7. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures in the era of cancer immunotherapy.
Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
[TBL] [Abstract][Full Text] [Related]
9. Boosting Checkpoint Immunotherapy with Biomaterials.
Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
[TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J; Chen J; Wang L
J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
[TBL] [Abstract][Full Text] [Related]
11. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
[TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
Zhang Q; Wu S
Front Immunol; 2022; 13():1063711. PubMed ID: 36713409
[TBL] [Abstract][Full Text] [Related]
14. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L
Front Immunol; 2023; 14():1334408. PubMed ID: 38259481
[TBL] [Abstract][Full Text] [Related]
15. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.
Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z
Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847
[TBL] [Abstract][Full Text] [Related]
17. Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer.
Esparcia-Pinedo L; Romero-Laorden N; Alfranca A
Front Immunol; 2023; 14():1231315. PubMed ID: 37622111
[TBL] [Abstract][Full Text] [Related]
18. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
Lauss M; Donia M; Svane IM; Jönsson G
Clin Cancer Res; 2022 May; 28(9):1751-1758. PubMed ID: 34965949
[TBL] [Abstract][Full Text] [Related]
19. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
[TBL] [Abstract][Full Text] [Related]
20. Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
Shen C; Zhang DL; Cheng XL; Zhang WC; Zhao JJ
Urol Int; 2023; 107(9):841-847. PubMed ID: 37769625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
